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Abstract SEA0400 is a recently developed inhibitor of the
Na+/Ca2+ exchanger (NCX) shown to suppress both forward
and reverse mode operation of NCX. Present experiments
were designed to study the effect of partial blockade of NCX
on Ca handling and contractility in Langendorff-perfused
guinea pig hearts loaded with the fluorescent Ca-sensitive
dye fura-2. Left ventricular pressure and intracellular calcium
concentration ([Ca2+]i) were synchronously recorded before
and after cumulative superfusion with 0.3 and 1 μM
SEA0400. SEA0400 caused no significant change in the
systolic and diastolic values of left ventricular pressure and
[Ca2+]i. Accordingly, pulse pressure and amplitude of the
[Ca2+]i transient also remained unchanged in the presence of
SEA0400. SEA0400 had no influence either on the time
required to reach peak values of pressure and [Ca2+]i or on
half relaxation time. On the other hand, both 0.3 and 1 μM
SEA0400 significantly increased the decay time constant of
[Ca2+]i transients, obtained by fitting its descending limb
between 30% and 90% of relaxation, from 127±7 to 165±7
and 177±14 ms, respectively (P<0.05, n=6). In contrast to
the guinea pig hearts, rat hearts responded to SEA0400
treatment with increased [Ca2+]i transients and contractility.
These interspecies differences observed in the effect of
SEA0400 can be explained by the known differences in
calcium handling between the two species.
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Introduction
Na+/Ca2+ exchange (NCX) is a crucial mechanism of Ca2+
extrusion from the myocardium in various mammalian
species and as such is involved in the control of cardiac
contraction (Bers 2000; Reuter et al. 2005). In the forward
mode of action, it is responsible for the extrusion of Ca2+
that enters the cell during each cardiac cycle but also
contributes to Ca2+ influx in the early phase of systole
when working in a reverse mode (Bers 2000). Selective
inhibition of NCX has important therapeutic implications
since it was reported to prevent early and delayed after-
depolarizations (Watano et al. 1999; Nagy et al. 2004), to
restore the impaired Ca2+ handling in heart failure (Hobai et
al. 2004), and to reduce the ischemia/reperfusion-induced
cellular injuries and arrhythmias (Yamamura et al. 2001;
Takahashi et al. 2003). Major objection against the
therapeutic application of NCX blockers is based on the
assumption that they might elevate cytosolic Ca2+ concen-
tration ([Ca2+]i)—as can be logically expected if NCX is
the dominant mechanism of Ca2+ extrusion (Sipido et al.
2006). Indeed, the NCX blocker SEA0400 was shown to
increase [Ca2+]i and contractility significantly in murine
and rat myocardium (Tanaka et al. 2005; Acsai et al. 2007).
In contrast, SEA0400 increased the force of contraction by
only 5% or less in guinea pig ventricular myocardium
(Namekata et al. 2005; Tanaka et al. 2007), suggesting that
the inhibition of NCX may have less dramatic consequen-
ces in this species. In the present work, therefore, the effect
of SEA0400 on intracellular Ca2+ handling and contractility
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was studied in Langendorff-perfused guinea pig hearts,
which allows the investigation of NCX inhibition under
conditions close to physiological (i.e., when the tissue
structure and transmembrane ion channels and transporters
are intact and [Ca2+]i is not buffered by ethylene glycol
tetraacetic acid). We found that SEA0400 failed to affect
the magnitude of [Ca2+]i transients and contractility in this
preparation. These results are consistent with a limited
inhibitory effect of SEA0400 on the forward mode activity
of NCX under physiological conditions. This information is
crucial regarding the potential therapeutic application of the
compound.
Materials and methods
Effects of SEA0400 on [Ca2+]i transients and contractilty
were studied in six Langendorff-perfused guinea pig hearts.
The animals (weighing 300–500 g) were intraperitoneally
heparinized and anesthetized with Na-pentobarbital
(150 mg/kg). After the opening of the animal’s chest, the
heart was rapidly removed and fixed to the cannula of a
Langendorff-perfusion device. The heart was perfused with
a modified Kreb’s solution containing NaCl 118, KCl 4.7,
CaCl2 2.5, MgSO4 1.2, NaHCO3 25, Na2EDTA 0.5,
KH2PO4 0.23, and glucose 5.5 mM. The pH of this
perfusate was set to 7.4 when gassed with a mixture of
5% CO2 and 95% O2 at 37°C. The coronary flow rate,
controlled by a peristaltic pump, was adjusted to 10 ml
min−1 g−1. Left ventricular pressure (LVP) was continuously
monitored using a Braun 2021-02 arterial pressure transducer
that was connected to the left ventricular cavity (Edes and
Kranias 1990). The heart rate was maintained at 200 beats
per minute by left atrial pacing.
To record [Ca2+]i transients, the heart was loaded with the
acetoxymethylester form of the fluorescent dye, fura-2
(5 μM), added to the perfusate together with probenecid
(0.6 mM), synperonic (1.25 g/l), and albumin (50 g/l).
Probenecid was used to inhibit the unspecific anion
exchanger of the cell membrane to avoid the extrusion of
fura-2 from the cells. Synperonic and albumin enhanced
loading with fura-2-AM. Due to the presence of probenecid,
peak LVP was lower than normal, but under these
conditions, stable calcium signals were obtained for periods
as long as 120 min (Kristof et al. 1998). Fura-2 was excited
at both 340- and 380-nm wavelengths. The emitted light was
collected at 510 nm using a trifurcated quartz fiber optic
bundle connected to a Deltascan device (Photon Technology
International, New Brunswick, NJ, USA). [Ca2+]i was
measured as a fluorescent ratio (F340/F380). The analogue
signals of fluorescence and LVP were sampled at 1 kHz.
In each case, ten subsequent beats were averaged and stored
for analysis.
After stabilization of the contractile parameters and
[Ca2+]i transients, 25 min of control recording was
performed in Kreb’s solution. Then, SEA0400 was applied
in a cumulative manner: 0.3- and 1-μM concentrations
were consecutively perfused, each for 25 min. SEA0400
was dissolved in dimethyl sulfoxide (DMSO) so as having
a stock solution of 3 mM. Appropriate quantities of this
stock solution were added to the bath yielding 0.3- or 1-μM
final concentrations of SEA0400. All solutions contained
0.033% DMSO. This low concentration of DMSO had no
effect on the parameters studied.
The effects of 0.3 and 1 μM SEA0400 were assessed
also in Langendorff-perfused rat hearts. In these experi-
ments, the ratiometric fluorescent dye, indo-1, was applied
to record intracellular Ca2+ transients. The hearts were
loaded with 1 μM indo-1-AM for 30 min. The dye
accumulated in the left ventricular wall was excited at
355 nm, and the fluorescence emission of the saturated and
free Ca2+ levels were detected at 400 and 500 nm after
correction for nonspecific background fluorescence. [Ca2+]i
was expressed as a fluorescent ratio (F/F0). The effects of
SEA0400 in these rat hearts were studied in a noncumu-
lative manner following a 20-min period of incubation with
concentrations of 0.3 (n=6) and 1 μM (n=8).
Results are expressed as mean±SEM values. Statistical
significance of differences was evaluated with using one-way
analysis of variance followed by Dunnett’s test. Differences
were considered significant when P was less than 0.05.
Results
The effect of 25-min consecutive perfusion with 0.3 and
1 μM of SEA0400 was studied in six Langendorff-perfused
guinea pig hearts. As shown by the analogue records
presented in Fig. 1a, SEA0400 had no obvious effect on the
LVP in these preparations. No significant change was
observed in the systolic pressure (55.5±2.7 mmHg in
control versus the 58.6±3.5 and 53.0±3.9 mmHg measured
at the end of 0.3 and 1 μM SEA0400 perfusion, re-
spectively), end-diastolic pressure (6.0±0.2 vs. 6.8±0.4 and
6.4±0.4 mmHg), and pulse pressure (49.5±2.8 vs. 51.8±
3.5 and 46.6±3.8 mmHg). The fluorescent ratio, used as
indicator of [Ca2+]i, was also unchanged by the SEA0400
perfusion, as shown in Fig. 2b. The respective values for
the peak fluorescent ratio were 1.04±0.01 vs. 1.04±0.02
and 1.05±0.03, for the baseline fluorescent ratio: 0.81±
0.04 vs. 0.81±0.04 and 0.83±0.04, and for fluorescent
ratio, amplitude values of 0.23±0.03 vs. 0.22±0.03 and
0.22±0.03 were obtained. The changes of these parameters
as a function of time are presented in Fig. 2.
Kinetic properties of pressure changes were characterized
by time required to develop peak pressure (TtP), time
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required to achieve half relaxation (HRT), and by the
maximum and minimum values of first time derivatives of
the pressure (+dP/dt, −dP/dt) obtained during systole and
diastole, respectively. No significant changes were ob-
served in any of these parameters (Fig. 3a,b). The [Ca2+]i
transients obtained before and after SEA0400 treatment
were analyzed in a similar manner, except for a segment of
the decaying phase of the curve (from 30% to 90% of
relaxation), which was fitted to a monoexponential func-
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Fig. 2 Effect of 0.3 and 1 μM SEA0400 on systolic (a), end-diastolic
(b), and pulse pressure (c) as a function of time. Lower panels (d, e, f)
show parameters of the concomitantly recorded [Ca2+]i transients:
fluorescent ratios measured during systole, diastole, and their
difference (Rpeak a, Rbase b, and Ramplitude c, respectively). Symbols


































Control 0.3 µM SEA0400 1 µM SEA0400 
150 ms
Fig. 1 Representative set of
analogue records showing the
changes in left ventricular
pressure (LVP, a) and cytosolic
free calcium concentration
(expressed as a fluorescent
ratio of F340/F380, b) in a
Langendorff-perfused guinea
pig heart before and after 25 min
cumulative perfusion with 0.3
and 1 μM SEA0400
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caused no significant change in the TtP and HRT values
obtained for the fluorescent ratio; however, the decay time
constant was significantly increased by 0.3 and 1 μM
SEA0400 (from 127±7 to 165±7 and 177±14 ms, respec-
tively, P<0.05).
The effect of 0.3 and 1 μM of SEA0400 was studied in
Langendorff-perfused rat hearts as well. As shown in
Fig. 4a–f, the developed pressure and the amplitude of the
[Ca2+]i transient was significantly increased following
20-min perfusion with 0.3 and 1 μM SEA0400 studied in
six and eight rat hearts, respectively. These results indicate
that SEA0400 was able to increase the amplitude of [Ca2+]i
transient and contractility in rat but not in guinea pig
ventricular myocardium. Another set of positive control
experiments is presented in Fig. 5a–f, where a guinea pig
heart was exposed to 100 nM isoproterenol for 1 min. Iso-
proterenol strongly increased the amplitude of both [Ca2+]i
transient and the developed pressure; in addition, it
enhanced the rate of contraction and relaxation—as it could
be expected in case of a preparation working under
reasonably good metabolic conditions. Similar responses
were observed whenever guinea pig hearts were challenged
by 100 nM isoproterenol.
Discussion
The major finding of the present study was that SEA0400-
induced partial NCX blockade failed to alter the developed
pressure and [Ca2+]i transients in Langendorff-perfused
guinea pig hearts. This is apparently in sharp contrast with
the present results obtained with Langendorff-perfused rat
hearts and previous observations in rat and murine
ventricular cardiomyocytes, where SEA0400 increased both
contractility and [Ca2+]i transients (Acsai et al. 2007;
Tanaka et al. 2005). This paradoxical situation can be
resolved by considering the differences in the conditions
that determine the operation of NCX, i.e., the actual values
of transmembrane potential and cytosolic free sodium and
calcium ion concentrations (Blaustein and Lederer 1999).
Action potential duration is much shorter (50 versus
250 ms), and intracellular sodium concentration is much
higher (15 versus 8 mM) in rats and mice than in other
mammalian species including guinea pig (Bers 2001).
Therefore, NCX operates dominantly in the forward mode
during systole in rats and mice, while the longer action
potential duration and lower intracellular sodium concen-
tration allow NCX to operate in the reverse mode for a
longer period of time during early systole in guinea pigs
(Bers 2001). As a consequence, symmetrical NCX inhibi-
tion (i.e., equal fractional blockade of the forward and
reverse mode operation) is expected to cause a greater
increase in [Ca2+]i in rats or mice than in guinea pigs. On
the other hand, since SEA0400 was shown to inhibit the
reverse mode operation of NCX more effectively than its
forward mode activity (Lee et al. 2004), SEA0400 is likely
to suppress calcium influx via NCX more effectively in
guinea pigs than in rats and mice. This favors calcium
accumulation in SEA0400-treated rat and murine hearts in
contrast to guinea pig myocardium. Similarly to the present
observations, SEA0400 had no effect on contractility in
anesthetized dogs (Takahashi et al. 2004). These results
together suggest that NCX inhibition may increase [Ca2+]i




















































































Fig. 3 Kinetic properties of
changes in left ventricular pres-
sure (a, b) and [Ca2+]i transients
(c, d) in the absence and pres-
ence of SEA0400. TtP Time
required to develop peak pressure
(a) or peak [Ca2+]i (c), HRT half
relaxation time of pressure (a) or
[Ca2+]i (c). Maximum and mini-
mum values of first time deriva-
tives of the pressure (+dP/dt and
−dP/dt, obtained during systole
and diastole, respectively) are
depicted in b. d Decay time
constant of [Ca2+]i transients
obtained by monoexponential fit
(from 30% to 90% of relaxation,
as shown in the inset). Symbols
and bars represent means±SEM
obtained in six hearts; asterisks
indicate significant changes from
control values, measured just
prior to SEA0400 treatment










































































































Fig. 5 Representative set of
analogue records showing the
changes in LVP (a, b), in their
first time derivatives, dP/dt
(c, d) and in [Ca2+]i transients,
(e, f) recorded from a
Langendorff-perfused guinea
pig heart before (a, c, e) and
1 min after (b, d, f) perfusion



































































































































































Fig. 4 Effect of SEA0400 on LVP and [Ca2+]i in Langendorff-
perfused rat hearts. Representative set of analogue records showing
the changes in LVP (a, b) and [Ca2+]i transients, displayed as changes
in the fluorescent ratio of F/F0, (d, e) before and after 20-min
perfusion with 0.3 (a, d) and 1 μM (b, e) SEA0400. c Average values
of developed pressure obtained in the absence and the presence of
0.3 (n=6) and 1 μM SEA0400 (n=8). f Respective average values
obtained for the [Ca2+]i amplitudes. Columns and bars represent mean
values±SEM; asterisks indicate significant changes from control
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species having a short action potential duration, like mice
or rats, but not in other mammals likely including humans.
However, the fact that the suppression of NCX failed to
elevate [Ca2+]i in guinea pig myocardium requires further
explanations. In the absence of a direct effect of SEA0400 on
sarcoplasmic Ca2+ transport, this is only possible if the net
effect of SEA0400 on transmembrane Ca2+ transport is close
to zero, i.e., if the effects on the outward and inward Ca2+
fluxes are approximately equal. According to previous
results, 1 μM SEA0400 blocked 80% of the inward NCX
current in guinea pig and 60% of it in canine ventricular cells
under patch-clamp conditions when [Ca2+]i was kept at low
levels (Tanaka et al. 2002; Birinyi et al. 2005). This extent of
NCX inhibition is expected to cause [Ca2+]i accumulation,
resulting in increased [Ca2+]i transients and contractility, if
NCX is really the main mechanism of calcium extrusion
from cardiac cells. Since such changes clearly failed to occur
in the present experiments, one must assume that either the
SEA0400-induced NCX inhibition is strongly reduced under
physiological conditions (i.e., when [Ca2+]i is not buffered)
or SEA0400 may decrease calcium entry via L-type calcium
channels as well. Indeed, the NCX-inhibitory effect of
SEA0400 was found to be partially attenuated when [Ca2+]i
was increased (Lee et al. 2004; Bouchard et al. 2004), in
accordance with our previous results obtained in canine
ventricular cells indicating that the inhibitory effect of
SEA0400 was halved when [Ca2+]i was increased from
55 nM to 1 μM (Birinyi et al. 2008). Furthermore, 1 μM
SEA0400 was shown to decrease the L-type calcium current
in canine (Birinyi et al. 2005), rat (Acsai et al. 2007), and
guinea pig (Tanaka et al. 2002) ventricular myocytes. Thus,
in the case of SEA0400, both mechanisms are likely to be
involved in balancing the reduced calcium extrusion.
At present, SEA0400 seems to be one of the most selective
NCX blockers developed for therapeutic use, since it fails to
modify ion currents in the surface membrane other than ICa
(Tanaka et al. 2002). The combined suppression of INa/Ca and
ICa is not a unique feature of SEA0400 but has also been
observed with several antiarrhythmic agents, like amiodarone
(Watanabe and Kimura 2000), bepridil (Watanabe and
Kimura 2001), or aprindine (Watanabe et al. 2002).
Concomitant suppression of INa/Ca and ICa may be therapeu-
tically beneficial, since due to the parallel reduction of
transmembrane Ca2+ influx and efflux, Ca2+ balance can be
achieved at a lower cost of metabolic energy. Thus,
SEA0400 is able to effectively decrease NCX activity under
pathological conditions (i.e., during an ischemia/reperfusion
episode) preventing thereby the proarrhythmic consequences
of an ischemic injury (Takahashi et al. 2003) without leading
to calcium overload in normal cardiac tissues.
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